Today: 17 April 2026
CoreWeave (CRWV) stock today: Credit agreement amendment puts liquidity covenant in focus after Friday surge
4 January 2026
2 mins read

CoreWeave (CRWV) stock today: Credit agreement amendment puts liquidity covenant in focus after Friday surge

NEW YORK, January 3, 2026, 20:10 ET — Market closed

  • CoreWeave disclosed an amendment to its DDTL 3.0 credit agreement, easing minimum liquidity and delaying some covenant tests.
  • Shares last closed up 10.77% at $79.32 on Friday, after trading between $73.16 and $81.17.
  • Next catalysts include the amendment exhibit in the coming Form 10-K and an estimated Feb. 9 earnings window on Nasdaq’s calendar.

CoreWeave, Inc. said it amended a credit agreement tied to its DDTL 3.0 facility, a regulatory filing showed.

Shares of the AI cloud provider closed Friday up 10.77% at $79.32, data showed.

The amendment lands as investors weigh how quickly debt-heavy AI infrastructure companies can keep adding capacity without tripping lender safeguards. Covenants — rules inside loan documents that require cash levels or financial ratios — can force a borrower to raise funding or curb spending if it falls short.

DDTL stands for delayed-draw term loan, which lets a borrower take down funding over time rather than all at once. CoreWeave said the change was meant to align the facility with the timing of deliveries discussed on its earnings call for the quarter ended Sept. 30, 2025.

The amendment, signed on Dec. 31, changes the DDTL 3.0 credit agreement originally dated July 28, 2025, with MUFG Bank as administrative agent and U.S. Bank among the counterparties, the filing said. It cuts the minimum liquidity amount (cash and other readily available funds) for monthly payment dates ending on and after March 1, 2026 and prior to May 1, 2026 to $100 million, and postpones the first tests of the debt service coverage ratio — a cashflow-to-debt-payment metric — until Oct. 31, 2027 and the contract realization ratio until Feb. 28, 2026. CoreWeave said it can use an unlimited number of “equity cures” — equity injections to remedy a covenant breach — until Oct. 28, 2026, subject to limits after that. SEC

Broader U.S. equities were mixed on Friday, with the Nasdaq easing while the S&P 500 and Dow finished higher as traders watched bond yields and the Federal Reserve outlook. CoreWeave outperformed that tape.

CoreWeave has leaned on capital markets to fund rapid buildouts of AI data-center capacity. In December it priced an upsized $2.25 billion offering of 1.75% convertible senior notes due 2031, according to a company statement. Convertible notes are debt that can convert into shares, potentially diluting existing holders.

Debt has become a flashpoint for skeptics. “They have to keep borrowing more and more because they spend more money than they can get,” D.A. Davidson analyst Gil Luria told The Verge. The Verge

CoreWeave trimmed its annual revenue forecast in November after data center partner delays, Reuters reported, sharpening investor focus on delivery schedules and financing needs.

Before the next session, investors will look for the full amendment text in CoreWeave’s annual report, which the company said would include it as an exhibit. Nasdaq’s earnings calendar listed Feb. 9 as an estimated report date, though companies often confirm dates closer to the release.

Technicians will watch whether the stock can hold Friday’s breakout above the prior close around $71.61. The shares traded between $73.16 and $81.17 and changed hands in a volume of about 30 million shares.

Macro data could set the tone for high-growth AI names next week, with investors watching the U.S. jobs report due on Jan. 9 for clues on rates and risk appetite, a Reuters column said.

For CoreWeave, the immediate question is whether covenant breathing room and delivery timing translate into steadier cash metrics once markets reopen. Any further funding moves or customer capacity updates are likely to keep the stock volatile.

Stock Market Today

  • India's FX Curbs Raise Hedging Costs, Weigh on Bonds and Equities amid Iran War Risks
    April 17, 2026, 4:51 AM EDT. Foreign institutional investors (FIIs) are growing cautious on India as new foreign exchange (FX) restrictions by the Reserve Bank of India (RBI) raise hedging costs for rupee exposure. The RBI's curbs, aimed at limiting arbitrage trades, have driven up one-year hedging costs by around 30 basis points onshore and nearly 70 basis points offshore via non-deliverable forward (NDF) markets, making Indian bonds less attractive. Concurrently, concerns over economic fallout from the Iran war and rising oil prices-India imports 90% of its oil-have pressured equities. Since the conflict began, foreign investors have offloaded $2.26 billion in government debt and $38 billion in shares, with record $12.7 billion equity outflows in March alone. Market strategists expect subdued sentiment and possibly higher bond yields before inflows return.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 17.04.2026

17 April 2026
LIVEMarkets rolling coverageStarted: April 17, 2026, 12:00 AM EDTUpdated: April 17, 2026, 4:55 AM EDT India's FX Curbs Raise Hedging Costs, Weigh on Bonds and Equities amid Iran War Risks April 17, 2026, 4:51 AM EDT.Foreign institutional investors (FIIs) are growing cautious on India as new foreign exchange (FX) restrictions by the Reserve Bank of India (RBI) raise hedging costs for rupee exposure. The RBI's curbs, aimed at limiting arbitrage trades, have driven up one-year hedging costs by around 30 basis points onshore and nearly 70 basis points offshore via non-deliverable forward (NDF) markets, making Indian bonds less attractive. Concurrently,
Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

16 April 2026
Hims & Hers Health shares rose to $26.65 Thursday after the FDA said it would reconsider restrictions on several peptides, removing 12 from a high-risk list and scheduling a July review of seven more. The move follows Hims’ March decision to stop advertising compounded GLP-1 drugs and expand branded offerings through Novo Nordisk. The company acquired a California peptide facility last year to bolster supply.
NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

16 April 2026
NuScale Power shares jumped to $13.23 before falling back to $11.52 Thursday after the White House ordered NASA to start a space-reactor program and Energy Secretary Chris Wright said initial U.S. reactors would likely get federal loans. NuScale remains the only U.S. firm with an approved small modular reactor design but has yet to secure firm orders or financing.
SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

16 April 2026
SoFi Technologies shares rose 1.5% Thursday after launching instant bank transfers via its Galileo platform, allowing money to move between SoFi and outside banks in seconds. The stock traded near $19.08 in New York. Investors await first-quarter results April 29, with SoFi guiding to $1.04 billion in adjusted net revenue and 12 cents per share in adjusted earnings.
D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

16 April 2026
D-Wave Quantum shares climbed about 5% Thursday, extending a 22.6% surge after Nvidia launched Ising, a new AI model family for quantum computing. D-Wave traded at $21.81, up from last year’s lows, and reported 2025 revenue of $24.6 million with first-quarter 2026 bookings topping $32.8 million. The company completed its $250 million Quantum Circuits acquisition in January. Market cap stood near $8.4 billion.
NexGen Energy stock jumps 11% as uranium miners rally — here’s what investors watch next
Previous Story

NexGen Energy stock jumps 11% as uranium miners rally — here’s what investors watch next

Via Transportation stock tumbles 6% to start 2026 as yields rise and data week looms
Next Story

Via Transportation stock tumbles 6% to start 2026 as yields rise and data week looms

Go toTop